Alam Kamran's Form 4 filing
Taysha Gene Therapies, Inc. (TSHA) · filed Aug 22, 2022
- Accession no.
- 0001209191-22-047097
- Filed
- Aug 22, 2022
- Trade date
- Aug 18-22, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $106.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Alam KamranCIK 0001793412 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | Common Stock | SSaleDisposed | −7,476 | $3.87 | −$28,932.12 | 290,645 | Direct | |
| Aug 19, 2022 | Common Stock | SSaleDisposed | −11,482 | $3.75 | −$43,057.5 | 279,163 | Direct | |
| Aug 22, 2022 | Common Stock | SSaleDisposed | −9,717 | $3.50 | −$34,009.5 | 269,446 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.